Clinical trial
Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis
NCT00142051 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis
- Lead sponsor
- Boston Children's Hospital
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- April 30, 2005
- Completion date
- August 31, 2013
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sickle cell disease